Preview

Tuberculosis and socially significant diseases

Advanced search

COMPARISON OF XPERT MBT/RIF CARTRIDGE TECHNOLOGY WITH MICROBIOLOGICAL METHODS FOR MBT DETECTION AND DRUG SUSCEPTIBILITY TESTING

Abstract

104 sputum samples obtained from the patients with pulmonary tuberculosis in the Central Research Institute for Tuberculosis of the Russian Academy of Medical Sciences were studied in order to compare the results of MBT detection and identification of drug susceptibility to rifampicin using test system Xpert MBT/RIF and classical microbiological methods. In addition, the aim of the research was to study the effect of concentrating of diagnostic specimens to an increase of the test Xpert MBT/RIF sensitivity. The Xpert MBT/RIF demonstrated most sensitivity with positive results in 78,2% of cases to compare with the native light microscopy of sputum, detecting 48,5% of cases, fluorescent microscopy of sputum sediment – 67,3%, cultural method with Lowenstein-Jensen medium – 56,4% and on BACTEC MGIT 960 – 71,3%.Concentration of sputum samples had no significant effect on the increase of the test sensitivity. Samples with identified non-tuberculous mycobacteria by the test Xpert MTB/RIF were recorded as negative ones, showing high specificity of the method. Complete coincidence of the results of rifampicin resistance detection using biological microchips and the system Xpert MBT/RIF was found.

About the Authors

S. N. Andreevskaya
ФГБУ «Центральный НИИ туберкулеза» РАМН, г. Москва
Russian Federation


T. G. Smirnova
ФГБУ «Центральный НИИ туберкулеза» РАМН, г. Москва
Russian Federation


E. E. Larionova
ФГБУ «Центральный НИИ туберкулеза» РАМН, г. Москва
Russian Federation


M. V. Burakova
ФГБУ «Центральный НИИ туберкулеза» РАМН, г. Москва
Russian Federation


I. A. Vasiljeva
ФГБУ «Центральный НИИ туберкулеза» РАМН, г. Москва
Russian Federation


L. N. Chernousova
ФГБУ «Центральный НИИ туберкулеза» РАМН, г. Москва
Russian Federation


References

1. Туберкулез в Российской Федерации 2011 г. Аналитический обзор статистических показателей, используемых в Российской Федерации и в мире. – М., 2013. – 280 с. (http://www.mednet.ru/images/stories/files/CMT/tbreview2011.pdf).

2. Нечаева О.Б. Ситуация по туберкулезу и работе противотуберкулезной службы Российской Федерации в 2012 г. (http://www.mednet.ru).

3. Приказ Минздрава России от 21.03.2003 г. № 109 «О совершенствовании противотуберкулезных мероприятий в Российской Федерации».

4. Siddiqi S., Rusch-Gerdes S. Руководство по работе с системой BACTEC MGIT 960, 2006.


Review

For citations:


Andreevskaya S.N., Smirnova T.G., Larionova E.E., Burakova M.V., Vasiljeva I.A., Chernousova L.N. COMPARISON OF XPERT MBT/RIF CARTRIDGE TECHNOLOGY WITH MICROBIOLOGICAL METHODS FOR MBT DETECTION AND DRUG SUSCEPTIBILITY TESTING. Tuberculosis and socially significant diseases. 2013;(2):25-29. (In Russ.)

Views: 18


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2413-0346 (Print)
ISSN 2413-0354 (Online)